• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRF1、TRF2、TIN2、TERT、KU70和BRCA1蛋白的表达与端粒缩短相关,可能在胃癌的多阶段致癌过程中发挥作用。

Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.

作者信息

Hu Hua, Zhang Yang, Zou Mei, Yang Shuai, Liang Xiao-Qiu

机构信息

Cancer Research Institute, The Second Affiliated Hospital, University of South China, 421001, Hengyang, Hunan, People's Republic of China.

出版信息

J Cancer Res Clin Oncol. 2010 Sep;136(9):1407-14. doi: 10.1007/s00432-010-0795-x. Epub 2010 Feb 2.

DOI:10.1007/s00432-010-0795-x
PMID:20127252
Abstract

PURPOSE

Telomere dysfunction is believed to be a significant factor in carcinogenesis. To elucidate the carcinogenesis mechanism in gastric cancer, the expression of telomeric proteins and changes in telomere length were investigated during multistage carcinogenesis of gastric cancer.

METHODS

Tissue samples were obtained during surgical operations from the normal gastric mucosa of 10 patients, the precancerous lesions of 15 patients, the gastric cancer tissues (GC) of 20 patients, and of tumors due to gastric cancer with lymph node metastasis (GCLM) from 5 patients. The expression of TRF1, TRF2, and TIN2 proteins was measured by Western blotting, while the expression of TERT, KU70, and BRCA1 proteins was detected using the immunohistochemical method. The mean telomere length was determined by Southern blotting.

RESULTS

Compared with normal gastric mucosa tissues, the expression of TRF1, TRF2, and TIN2 proteins was significantly higher in precancerous lesions, GC, and GCLM (P < 0.01). The expression of TRF1, TRF2, and TIN2 proteins was significantly higher in GC and GCLM than in precancerous lesions (P < 0.01). The expression of TERT and Ku70 proteins in precancerous lesions and GC tissues was significantly higher than that in normal gastric mucosa tissues (P < 0.01). The expression of TERT and Ku70 proteins in GC tissues was significantly higher than in precancerous lesions (P < 0.01). In normal gastric mucosa, the BRCA1 protein was primarily located in the cell nucleus. In precancerous lesions and GC, the expression of the BRCA1 protein was apparent in the cell cytoplasm. The mean telomere length in precancerous lesions, GC, and GCLM was significantly shorter than that in normal gastric mucosa tissues (P < 0.05). The mean telomere length in GC and GCLM was significantly shorter than that in precancerous lesions (P < 0.05). The mean telomere length in all tissue samples was inversely correlated with the level of TRF1, TRF2, TIN2, TERT, and Ku70 proteins.

CONCLUSIONS

Our results suggest that the over-expression of telomeric proteins, TRF1, TRF2, TIN2, TERT, and Ku70, and the transposition of the BRCA1 protein may work together to reduce the telomere length in precancerous lesions and gastric cancer, and could contribute to the multistage carcinogenesis of gastric cancer. These findings offer new insight into the mechanism of carcinogenesis in gastric cancer.

摘要

目的

端粒功能障碍被认为是致癌作用中的一个重要因素。为阐明胃癌的致癌机制,在胃癌的多阶段致癌过程中研究了端粒蛋白的表达及端粒长度的变化。

方法

在手术过程中获取了10例患者正常胃黏膜、15例患者癌前病变、20例患者胃癌组织(GC)以及5例伴有淋巴结转移的胃癌肿瘤组织(GCLM)的组织样本。通过蛋白质免疫印迹法检测TRF1、TRF2和TIN2蛋白的表达,采用免疫组织化学方法检测TERT、KU70和BRCA1蛋白的表达。通过Southern印迹法测定平均端粒长度。

结果

与正常胃黏膜组织相比,癌前病变、GC和GCLM中TRF1、TRF2和TIN2蛋白的表达显著更高(P < 0.01)。GC和GCLM中TRF1、TRF2和TIN2蛋白的表达显著高于癌前病变(P < 0.01)。癌前病变和GC组织中TERT和Ku70蛋白的表达显著高于正常胃黏膜组织(P < 0.01)。GC组织中TERT和Ku70蛋白的表达显著高于癌前病变(P < 0.01)。在正常胃黏膜中,BRCA1蛋白主要位于细胞核。在癌前病变和GC中,BRCA1蛋白在细胞质中表达明显。癌前病变、GC和GCLM中的平均端粒长度显著短于正常胃黏膜组织(P < 0.05)。GC和GCLM中的平均端粒长度显著短于癌前病变(P < 0.05)。所有组织样本中的平均端粒长度与TRF1、TRF2、TIN2、TERT和Ku70蛋白的水平呈负相关。

结论

我们的结果表明,端粒蛋白TRF1、TRF2、TIN2、TERT和Ku70的过度表达以及BRCA1蛋白的转位可能共同作用以缩短癌前病变和胃癌中的端粒长度,并可能促成胃癌的多阶段致癌过程。这些发现为胃癌的致癌机制提供了新的见解。

相似文献

1
Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.TRF1、TRF2、TIN2、TERT、KU70和BRCA1蛋白的表达与端粒缩短相关,可能在胃癌的多阶段致癌过程中发挥作用。
J Cancer Res Clin Oncol. 2010 Sep;136(9):1407-14. doi: 10.1007/s00432-010-0795-x. Epub 2010 Feb 2.
2
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.端粒结合蛋白表达水平与乳腺癌中端粒长度的协调调控。
Cancer Med. 2012 Oct;1(2):165-75. doi: 10.1002/cam4.14. Epub 2012 Jul 24.
3
Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.端粒重复序列结合因子1、2及TRF1相互作用核蛋白2在人胃癌中的表达
Int J Oncol. 2001 Sep;19(3):507-12.
4
Human Telomere Repeat Binding Factor TRF1 Replaces TRF2 Bound to Shelterin Core Hub TIN2 when TPP1 Is Absent.当 TPP1 缺失时,端粒重复结合因子 TRF1 取代结合在 shelterin 核心 hub TIN2 上的 TRF2。
J Mol Biol. 2019 Aug 9;431(17):3289-3301. doi: 10.1016/j.jmb.2019.05.038. Epub 2019 May 31.
5
Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.TRF1、TRF2和TIN2基因的下调对于维持胃癌的端粒DNA很重要。
Anticancer Res. 2002 Nov-Dec;22(6A):3303-7.
6
TIN2 mediates functions of TRF2 at human telomeres.TIN2介导TRF2在人类端粒处的功能。
J Biol Chem. 2004 Oct 15;279(42):43799-804. doi: 10.1074/jbc.M408650200. Epub 2004 Aug 3.
7
TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.TRF2 连接的 TIN2 可以通过 TPP1/POT1 介导端粒保护。
Mol Cell Biol. 2014 Apr;34(7):1349-62. doi: 10.1128/MCB.01052-13. Epub 2014 Jan 27.
8
Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.端粒重复序列结合因子2的敲低可增强肿瘤放射敏感性,而与端粒酶状态无关。
J Cancer Res Clin Oncol. 2015 Sep;141(9):1545-52. doi: 10.1007/s00432-015-1911-8. Epub 2015 Jan 22.
9
A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2.端粒长度调节因子TRF1与染色体末端保护因子TRF2之间的动态分子联系。
Curr Biol. 2004 Sep 21;14(18):1621-31. doi: 10.1016/j.cub.2004.08.052.
10
Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.MRE11复合物(MRE11、RAD50、NBS1)和hRap1在人胃癌中的表达及其与端粒调控、端粒酶活性的关系。
Pathobiology. 2001;69(4):219-24. doi: 10.1159/000055946.

引用本文的文献

1
Telomere Maintenance and DNA Repair: A Bidirectional Relationship in Cancer Biology and Therapy.端粒维持与DNA修复:癌症生物学与治疗中的双向关系
Cancers (Basel). 2025 Jul 9;17(14):2284. doi: 10.3390/cancers17142284.
2
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
3
Combatting cellular immortality in cancers by targeting the shelterin protein complex.通过靶向庇护蛋白复合物来对抗癌症中的细胞不朽性。

本文引用的文献

1
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.端粒维持基因表达的变化提示B细胞慢性淋巴细胞白血病中存在整体端粒功能障碍。
Blood. 2008 Feb 15;111(4):2388-91. doi: 10.1182/blood-2007-09-111245. Epub 2007 Dec 12.
2
Telomere maintenance through spatial control of telomeric proteins.通过端粒蛋白的空间控制实现端粒维持。
Mol Cell Biol. 2007 Aug;27(16):5898-909. doi: 10.1128/MCB.00603-07. Epub 2007 Jun 11.
3
Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination.
Biol Direct. 2024 Nov 22;19(1):120. doi: 10.1186/s13062-024-00552-4.
4
Expression and functional analyses of TERF2 in esophageal carcinoma.TERF2在食管癌中的表达及功能分析
Heliyon. 2024 Sep 18;10(18):e38040. doi: 10.1016/j.heliyon.2024.e38040. eCollection 2024 Sep 30.
5
Among-population variation in telomere regulatory proteins and their potential role as hidden drivers of intraspecific variation in life history.端粒调节蛋白的种群间变异及其作为生活史种内变异潜在隐藏驱动因素的作用。
J Anim Ecol. 2025 Mar;94(3):303-315. doi: 10.1111/1365-2656.14071. Epub 2024 Mar 21.
6
Exploring gene-patient association to identify personalized cancer driver genes by linear neighborhood propagation.通过线性近邻传播探索基因-患者关联,以鉴定个性化癌症驱动基因。
BMC Bioinformatics. 2024 Jan 22;25(1):34. doi: 10.1186/s12859-024-05662-4.
7
Canine sperm motility is associated with telomere shortening and changes in expression of shelterin genes.犬精子活力与端粒缩短和庇护素基因表达变化有关。
BMC Vet Res. 2023 Nov 10;19(1):236. doi: 10.1186/s12917-023-03795-x.
8
Proteomic Profiles and Protein Network Analysis of Primary Human Leukocytes Revealed Possible Clearance Biomarkers for Staphylococcus aureus Infection.原发性人白细胞蛋白质组学特征和蛋白质网络分析揭示了金黄色葡萄球菌感染可能的清除生物标志物。
Curr Microbiol. 2023 Sep 4;80(10):335. doi: 10.1007/s00284-023-03450-6.
9
An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).端粒和端粒酶在肿瘤前病变中的作用概述(综述)
Mol Clin Oncol. 2023 Jun 22;19(2):61. doi: 10.3892/mco.2023.2657. eCollection 2023 Aug.
10
An Update to Hallmarks of Cancer.《癌症特征的最新进展》
Cureus. 2022 May 7;14(5):e24803. doi: 10.7759/cureus.24803. eCollection 2022 May.
Ku70刺激功能失调的端粒融合,但保护染色体末端免受同源重组影响。
Nat Cell Biol. 2006 Aug;8(8):885-90. doi: 10.1038/ncb1444. Epub 2006 Jul 16.
4
Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.成人T细胞白血病患者中端粒长度调节因子TRF1、TRF2和TIN2的表达增加。
Int J Cancer. 2006 Nov 1;119(9):2090-7. doi: 10.1002/ijc.22026.
5
The structure and function of telomerase reverse transcriptase.端粒酶逆转录酶的结构与功能。
Annu Rev Biochem. 2006;75:493-517. doi: 10.1146/annurev.biochem.75.103004.142412.
6
Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.结直肠癌中端粒长度、端粒酶活性及端粒重复序列结合因子1表达的相关性
Cancer. 2006 Feb 1;106(3):541-51. doi: 10.1002/cncr.21625.
7
Expression of telomeric repeat binding factor 1 in non-small cell lung cancer.端粒重复序列结合因子1在非小细胞肺癌中的表达
J Surg Oncol. 2006 Jan 1;93(1):62-7. doi: 10.1002/jso.20421.
8
Shelterin: the protein complex that shapes and safeguards human telomeres.端粒保护蛋白复合体:塑造并保护人类端粒的蛋白质复合体。
Genes Dev. 2005 Sep 15;19(18):2100-10. doi: 10.1101/gad.1346005.
9
Telomeres and human disease: ageing, cancer and beyond.端粒与人类疾病:衰老、癌症及其他。
Nat Rev Genet. 2005 Aug;6(8):611-22. doi: 10.1038/nrg1656.
10
Recent advances in molecular diagnosis and therapy of gastric cancer.胃癌分子诊断与治疗的最新进展
Dig Dis. 2004;22(4):380-5. doi: 10.1159/000083602.